Anti-hepatitis C Activity of Meso-tetrakis-porphyrin Analogues

The present invention relates to porphyrin analogues, their use in pharmaceutical compositions alone, or combination with other agents and in the treatment and/or prophylaxis of flaviviridae viral infections, especially hepatitis C viral infection, and secondary disease states and/or conditions associated with same.

Patents:
US 20,110,064,694

Inventor(s): HAMILTON ANDREW [GB]; CHENG YUNG-CHI [US]

Type of Offer: Sale



« More Pharmaceutical Patents

---